This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects

Inclusion Criteria: * Provision of signed and dated, written informed consent prior to any study specific procedures. * Clinically normal physical findings and laboratory values as judged by the investigator with normal ECG. * Healthy male and female volunteers. Females must be of non childbearing potential. Exclusion Criteria: * Clinically significant illness or clinically relevant trauma, as judged by the investigator, within 4 weeks of the first administration of the Investigational Product * History of any disease or condition known to interfere with the absorption, distribution, metabolism or excretion of drugs